We invest in private equity and growth capital.

We invest in the healthcare and technology sectors. Active funds: - FIV $80M venture credit fund - FV $100M growth equity fund (still raising fund, upper limit $200M) We are one of Australia’s leading venture capital firms, with over $500 million in funds under management. But we do more than invest. We work with companies to take them to that all-important next stage, by actively shaping their future. We apply our years of experience, expertise, operational and executional excellence to accelerate their growth and launch them into global markets. And we’re now looking for new opportunities in the healthcare and technology sectors. Companies like those already in our portfolio with truly innovative products tackling multi-billion-dollar world problems, from needle-free vaccinations to next-generation learning technologies to virtual communications. Game-changers, that deliver lasting gains.

We invest in consumer products.

We invest in venture-scale companies tackling climate change and sustainability (energy, mobility & logistics, foodtech & agtech, circular economy, advanced manufacturing & materials, resiliency & adaptation)

We invest in private equity funds as part of diversified portfolios for qualified investors, seeking long-term illiquidity premiums and diversification benefits through disciplined manager selection and portfolio construction.

We invest in emerging technologies and emerging economies. Sector agnostic, mostly from Latam and US.

We invest across various industries globally.

We invest in creating long-term value.

We invest in early stage and growth technology companies, with a particular focus on greentech, medtech, and saas sectors.

We invest in real estate, utilizing private equity and debt strategies.

We invest in information technology services companies with high-growth potential.

We invest in companies across various sectors.

We invest in companies, bridging talent and capital.

We accelerate texas-based biotech entrepreneurs and researchers developing cancer therapeutics and oncology innovations at pre-ind to early clinical stages

We invest in debt capital solutions for lower middle market companies.

We invest in companies offering telecommunication and media services.

We invest in financial services.

We invest in promoting business.

We invest in diverse opportunities.

We invest in early-stage Moroccan startups after a 6-month incubation program.